Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

about

Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Item

http://www.wikidata.org/entity/Q36057314

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Toward Personalized Medicine: ...... Influence Patient Management?

@ast

Toward Personalized Medicine: ...... Influence Patient Management?

@en

type

Item

label

Toward Personalized Medicine: ...... Influence Patient Management?

@ast

Toward Personalized Medicine: ...... Influence Patient Management?

@en

prefLabel

Toward Personalized Medicine: ...... Influence Patient Management?

@ast

Toward Personalized Medicine: ...... Influence Patient Management?

@en

P1476

Toward Personalized Medicine: ...... Influence Patient Management?

@en

P2093

Stephanie M Ware

http://www.w3.org/2001/XMLSchema#string

Teresa M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Importance of genetic evaluation and testing in pediatric cardiomyopathy

Shared genetic causes of cardiac hypertrophy in children and adults

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands

Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and F

Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years

Truncations of titin causing dilated cardiomyopathy.

Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation

P304

43-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PPEDCARD.2015.01.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26380543

http://www.w3.org/2001/XMLSchema#string

P921

sarcomere

P932

4568845

http://www.w3.org/2001/XMLSchema#string